I fact checked the fact checkers and couldn’t believe what I found. Despite the corporate press, Big Pharma, and the federal government telling us otherwise, it is absolutely true that there is no FDA approved COVID-19 vaccine available in the United States today. And there are no plans to make one available any time soon.
I know it’s hard to believe, but it’s 100% true. And this reality implicates both Big Pharma and the US Public Health bureaucracy in an incredible scandal.
On August 23, the FDA granted full approval for a COVID-19 vaccine to Pfizer-BioNtech for a specific product sold under the brand name Comirnaty. The landmark moment — the “full approval” endorsement from the FDA — was heralded by the Biden Administration and countless states, and quickly leveraged to coerce millions into taking the shots. This product, Comirnaty, was fully authorized for the “prevention of COVID-19 disease in individuals 16 years of age and older.”
Yet Comirnaty itself has never made its way into the United States. The fully-approved version is nowhere to be found within our borders.
A separate product, which remains under emergency use authorization (EUA), is the only “Pfizer shot” available in the United States.
Early on, Pfizer and its government allies seemed to have a reasonable explanation for this issue. They claimed that Comirnaty was not yet available because the EUA shots were still lining the shelves, and claimed that the FDA-approved version would be available to all soon.
Now, it’s been over 4 months since full approval, and Comirnaty is still not being distributed.
The FDA has recognized Comirnaty as a “legally distinct” product with “certain differences,” but claims it does not impact safety or effectiveness of the shots. “Fact checkers” leverage the latter point of safety and efficacy to claim that people are still getting access to ingredients akin to the fully approved product.
But here’s the issue: they have yet to explain why people still can’t get Comirnaty, now 128 days after full approval.
And if it is the case that the two products are the exact same thing, the FDA has not explained why they only approved a distinct product named Comirnaty, and not the injection currently being sold under the EUA label. Why won’t the FDA approve the EUA product? Pfizer doesn’t want them to. You’ll see in a moment.
The CDC continues to confirm that Comirnaty is “not orderable at this time.” Moreover, the CDC currently states that “Pfizer does not plan to produce any product with these NDCs (National Drug Codes) and labels over the next few months while EUA authorized product is still available and being made available for US distribution.”
Now, back to the trillion dollar EUA question.
Pfizer is likely refusing to make the fully authorized version available, while continuing to sell an EUA product because doing so opens up Pfizer and BioNTech to legal liability issues. An EUA fully protects the drugmaker and grants zero legal recourse to the patient.
Now, here’s where it all gets very nefarious.
In order for Pfizer to be granted legal liability protection for their fully authorized Comirnaty shot, they must first secure full approval for the children’s version of their COVID-19 shot. Steve Kirsch has explained this at length last month on his Substack. Additionally, Robert Kennedy Jr mentioned it on a recent podcast with Mikhaila Peterson. I looked into these claims extensively, and they are completely accurate. The National Childhood Vaccine Injury Act (NCVIA), which was passed into law in 1986, provides a legal liability shield to drug manufacturers if they receive full authorization for all ages.
Pfizer needs approval for children so that it can protect itself from lawsuits. The company is working with regulators, even clandestinely altering vaccine ingredients (a process that should require them to get full approval for an entirely separate product), to clear the path to legal indemnity.
Pfizer has been enabled to change formulations on no publicly available data— Jean Rees (@JeanRees10) December 29, 2021
New - "Gray Cap" 12+ vax w/Tris (never trialed in any age for the Pfizer 💉)
Public 5-11 yos are 1st to receive Tris formulation, clinical trial was PBS.
FDA memo unclear on Comirnaty or BNT162b2 pic.twitter.com/ytwrIbCkOw
Now you know why Pfizer, Moderna, and others are working relentlessly to authorize their products for children, who face near-zero risk from COVID-19, but continue to showcase alarming side effects from the vaccine.
New Hong Kong study finds a 1-in-3000 adolescents developed myocarditis following vaccination— Chief Nerd (@TheChiefNerd) December 27, 2021
“There is a significant increase in the risk of acute myocarditis/pericarditis following Comirnaty vaccination among Chinese male adolescents, especially after the second dose.” pic.twitter.com/0WG9PYKDGM
once-healthy 12 yr old Maddy de Garay from Ohio was volunteered by her family for Pfizer trial— Steve Ross (@trencherman333) October 16, 2021
After 2 doses she is now paralyzed from the waist down, in a wheelchair, has seizures & memory loss
Her remorse-filled Mom said " we just wanted to show we believed in The Science..." pic.twitter.com/LkbusmMFB9
If Comirnaty was available for adults in the United States, Americans would be able sue Pfizer for vaccine injuries. If Comirnaty is for all ages, that means Pfizer receives extensive legal protection. Big Pharma is using children as legal human shields for their products. Let’s hope they don’t get away with it again.
There is currently no fully authorized COVID-19 vaccine available in the United States today, and this reality has been attacked relentlessly by the corporate press. "Fact checkers" at Newsweek, USA Today, Reuters the Associated Press, and elsewhere peddled false information to cover up this absolute fact.
If you run a Google search on this issue, you will find the aforementioned “fact checks” as evidence that Comirnaty is available, when it is most certainly not available. Nobody in the United States is receiving the legally distinct, fully authorized shot, because that shot makes Big Pharma and corrupt regulators more legally vulnerable than they want to be.
Reprinted with permission from The Dossier.
Subscribe and support the author here.